| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917717 | Radiotherapy and Oncology | 2016 | 12 Pages |
Abstract
RT may potentiate anti-melanoma activity of ICI by enhancing response on both target and non-target lesions. Several prospective trials are ongoing with the aim of further exploring this combination in the clinical setting, hopefully confirming initial observations and opening a new therapeutic window for advanced melanoma patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Andrea Riccardo Filippi, Paolo Fava, Serena Badellino, Chiara Astrua, Umberto Ricardi, Pietro Quaglino,